Pharmaceutical research and development

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about R&D in the pharmaceutical industry

This dossier presents key facts and figures about research and development in the pharmaceutical industry worldwide. The pharmaceutical industry is one of the segments most driven by innovation through research and development investments. This document gives you an overview about pharmaceutical R&D in general, the top companies, characteristics of the current R&D pipeline, and many more.

Table of contents

  • 1. Overview

    • Total global pharmaceutical R&D spending 2010-2024

    • Yearly growth rate of R&D spending in pharmaceutical industry 2003-2017

    • R&D spending growth worldwide on pharmaceuticals 2011-2024

    • Number of drugs in the R&D pipeline worldwide 2001-2019

    • Pharma companies worldwide with active R&D pipelines 2001-2019

    • Projected most valuable R&D projects based on net present value in 2018

  • 2. R&D performance by company

    • R&D spending share of top pharmaceutical companies 2018 and 2024

    • Top pharmaceutical companies in R&D spending growth 2017-2018

    • Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018

    • Top pharma companies worldwide 2019, by size of R&D pipeline

    • Distribution of pharmaceutical R&D companies by region 2019

  • 3. Characteristics of R&D pipeline

    • Top therapeutic categories worldwide 2019, by number of R&D products

    • Worldwide top diseases 2019, by number of active drugs

    • Worldwide top origins for pipeline drugs by number of active drugs 2019

    • Worldwide pipeline drugs by delivery route share 2019

    • Worldwide top drug producing mechanisms of action by number of active compounds 2019

  • 4. Costs and ROI

    • R&D cost to develop new pharmaceutical compounds 2010-2018

    • 3 year average R&D cost to develop new pharmaceutical compounds 2010-2018

    • Percentage return on R&D among large cap biopharma companies 2010-2018

    • Percentage return on R&D among mid cap biopharma companies 2013-2018

  • 5. Outsourced R&D

    • Leading global contract research organizations based on revenue 2017

    • Total addressable CRO market worldwide in 2018, by function

    • Total CRO market size worldwide 2013-2020

    • Outsourced research penetration in pharmaceutical industry worldwide 2011-2020

    • Size of U.S. healthcare CRO market 2016-2022 by type

  • 6. Opinions on pharma R&D

    • U.S. adults impression of the U.S. pharma companies amount of research

    • U.S. adults impression of the U.S. pharma companies quality of research

    • Willingness to pay more taxes for additional medical research - U.S. adults 2019

    • Importance to support private investments in medical research by government 2019

    • Importance of supporting research and innovation to personalize patient care US 2018

Order dossier
More than 7,500
companies trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Contact
Esther Shaulova
Operations Manager
support@statista.com +1 212 419 - 5770

Mon - Fri, 9am - 6pm, EST

Contact (Europe)
Lodovica Biagi
Operations Manager UK
eu.support@statista.com +44 203 709-9960

Mon - Fri, 9:30am - 5pm, GMT

Menu